Researchers release the brakes on the immune | EurekAlert!
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells | BMC Biology | Full Text
Immunotherapy as an advance in cancer medicine - Innovations Report
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Team | IMMEI
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Ich bin Prof. Annkristin Heine - Krebszentrum CIO Bonn | Facebook
G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Team | IMMEI
UKB NewsRoom | Annkristin Heine
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy,Journal of Cancer Research and Clinical Oncology - X-MOL
Team | IMMEI
CIO Bonn - Lymphomzentrum
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
Bjørn Heine Strand - NIPH
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Medicine®
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn
Prof. Dr. med. Annkristin Heine - Internist, Hämatologe & Internistischer Onkologe Bonn
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study
